Lundbeck.
Danish pharmaceutical company
- Reports this week
- 3
- Active events
- 2
- Connections
- 91
What's happening
Active this week
Earlier this month
One to three months ago
-
Lundbeck is presenting new data at the European Epilepsy Congress being held in Athens.Some support2 reports
-
European Commission granted orphan designation for Lundbeck's drug asedebart in the EU market.Some support3 reports
-
The FDA granted Fast Track designation to Lu AH69593, a treatment associated with Lundbeck.Some support1 report
Gone quiet
No new reports in 90+ days-
Lundbeck is leading a global Phase III trial, the DEEp OCEAN Trial, which is evaluating an investigational molecule.Some support6 reports
-
Lundbeck presents data at EAN Congress 2026.Some support2 reports
-
A study was presented at a meeting in Chicago involving Lundbeck and its R&D head, Johan Luthman.Some support1 report
-
UCB, Eisai, Lundbeck, and GW Pharmaceuticals are identified as key players in a market supported by supportive FDA policies.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Lundbeck this week
News at the entities that move Lundbeck most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Lundbeck
-
European Commission StructuralFinland has stopped issuing tourist visas to Russians, while other EU nations continue or object to the new visa policy.Moves Lundbeck
-
Food and Drug Administration StructuralFDA conducted a search operation in Pune on January 1, 2026.Moves Lundbeck
-
Illinois StructuralFelony case filings rose sharply in Cook County, amid policy changes mandated by Kim Foxx and data review by the Tribune.Moves Lundbeck
-
Greater Boston StructuralKenneth Olsen, who was a researcher at MIT, is mentioned in the context of institutional growth supported by state policy in the Greater Boston area, which includes Harvard University.Moves Lundbeck
-
Chicago Shared contextBritt Festival hosted events featuring Jim Gaffigan in Chicago on October 19, 2026.Moves Lundbeck
Connections
The 14 strongest of 91, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Greater Boston Structural
Lundbeck is establishing its US headquarters and a new hub within the Greater Boston area.
-
FDA Structural
The FDA granted Orphan Drug Designation to a product of Lundbeck, establishing a formal regulatory dependency for market approval.
-
Lars Fruergaard Jørgensen Structural
Lars Fruergaard Jørgensen is proposed to chair the board of Lundbeck.
-
Charl van Zyl Structural
Charl van Zyl holds the position of CEO at Lundbeck.
-
Ingrid Scheffer Structural
Ingrid Scheffer serves as the lead investigator for a clinical program associated with Lundbeck.
-
Food and Drug Administration Structural
The FDA granted Fast Track designation to a product developed by Lundbeck.
-
Wenzel Structural
Wenzel served as the chair of the Lundbeck board.
-
European Commission Structural
The European Commission regulates Lundbeck by granting specific product designations, such as orphan designation.
Show all 14 connections
-
Johan Luthman Structural
Johan Luthman serves as the Executive Vice President and Head of Research & Development at Lundbeck.
-
European Academy of Neurology Mentioned together
Lundbeck utilized the EAN Congress platform to present new clinical data.
-
Illinois Structural
Lundbeck established its business roots and operational presence within Illinois.
-
Chicago Shared context
Lundbeck is conducting business activities, including studies and meetings, within the geographical boundaries of Chicago.
-
Athens Shared context
Lundbeck is utilizing Athens as the location for presenting data at the European Epilepsy Congress.
-
Cambridge Shared context
Lundbeck operates within the geographic and regulatory context of Cambridge, Massachusetts.